Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 4,402 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Etf Ticker Symbol | Market | Type |
|---|---|---|---|
| SPDR S&P Biotech | XBI | AMEX | Exchange Traded Fund |
| Price Change | Change Percent | Etf Price | Last Traded
|
|
|---|---|---|---|---|
| -0.10 | -0.12% | 83.84 | 07:47:26 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 83.94 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 101 | 4,402 | - | 63.80 - 103.52 |
| Last Trade Time | Type | Quantity | Etf Price | Currency |
|---|---|---|---|---|
| 07:45:07 | 12 | 83.94 | USD |
SPDR S&P Biotech (XBI) Options Flow Summary
SPDR S&P Biotech Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 6.5B | 77.43M | - | 18.32M | 733.48M | 9.47 | 8.86 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News SPDR S&P Biotech
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
XBI Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 84.40 | 86.31 | 81.26 | 83.71 | 11,294,351 | -0.56 | -0.66% |
| 1 Month | 95.20 | 95.885 | 81.26 | 88.11 | 11,206,257 | -11.36 | -11.93% |
| 3 Months | 88.08 | 103.52 | 81.26 | 92.74 | 11,413,596 | -4.24 | -4.81% |
| 6 Months | 66.30 | 103.52 | 63.80 | 85.97 | 11,454,390 | 17.54 | 26.46% |
| 1 Year | 81.27 | 103.52 | 63.80 | 83.46 | 9,373,037 | 2.57 | 3.16% |
| 3 Years | 134.30 | 141.50 | 61.78 | 89.25 | 9,604,279 | -50.46 | -37.57% |
| 5 Years | 85.49 | 174.79 | 61.78 | 93.62 | 7,981,124 | -1.65 | -1.93% |
| The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI). |
